Bioline Rx Ltd - ADR
NASDAQ:BLRX
| Market Cap (Intraday) | 17.35M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $3.86 |
| 50-Day MA | $4.04 |
| 200-Day MA | $4.67 |
Bioline Rx Ltd - ADR Stock, NASDAQ:BLRX
Modi'in Technology Park, 2 HaMa'ayan Street, Modi'in, HaMerkaz 7177871
Israel
Phone: +972.8.642.9100
Number of Employees: 38
Description
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.